Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy
NCT01590615
·
clinicaltrials.gov ↗
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis B
Interventions
DRUG:
Anti-HBV nucleoside/nucleotide therapy
Sponsor
Gilead Sciences